TIMM17A and triple-negative breast carcinoma: In invasive and triple-negative breast cancer (TNBC), TIMM17A has been identified as a key target gene of miR-24-2 and miR-133b, with its low expression associated with improved survival, indicating diagnostic and therapeutic potential31,32.